Dear Colleagues,
The year 2024 is poised to be significant for our community and for CNP-COT, which will need to rally and support us around major projects.
2024 will be a year of continued efforts to establish the RENACOT registry (extension to hips and other joints). Our community has an obligation to deliver results to maintain credibility in the eyes of regulators and the international orthopedic community. RENACOT will also provide us with independence as the registry will be owned by orthopedic surgeons, enabling us to address institutional requests or health agencies while managing data (symposiums, trial promotion). This tool will allow us to shape health policies and thus our practice, and to advance our knowledge with undeniable data.
Certification, a long-discussed issue, will be implemented in the course of 2024, depending on the publication of decrees. Our specialty is technically prepared, with CNP-COT and Orthorisq ensuring it's a procedure that perfectly meets regulatory requirements, yet with a focus on simplification and ease of practice. Details of this mandatory procedure for all will be presented and communicated in the coming months.
Managing supply difficulties of implants. As you have noticed, several manufacturers have decided to discontinue equipment lines without providing substitutes (massive tumor prostheses, radial head prostheses, hip revision prostheses, etc.). Manufacturers often cite the Medical Device Regulation (MDR) and economic constraints. CNP-COT's mission is to establish links between manufacturers and various agencies (ANSM, HAS, CEPS) so that ongoing requests are expedited to offer patients substitute implants. Similarly, we are engaging in discussions with manufacturers and health agencies to limit these withdrawals, especially for products in high demand (i.e., with limited or no substitution possibility).
Supporting SOFCOT symposiums, highlights of our society's life. We have been made aware of directors' difficulties related to regulatory requirements for protocol drafting. To address this, we have reached out to several companies to provide assistance, starting from the upcoming symposiums. In this regard, the RENACOT registry will be an important tool for simplifying data collection.
The overhaul of the nomenclature has been initiated under difficult conditions, knowing that at best, this work will be done with a "constant budget envelope," so it is very important to participate in prioritizing acts for fair revaluation. To this end, a survey supported by CNP and Orthorisq will be open to all members who wish to engage and participate.
For our 2024 congress, we will maintain the specialty tracks, although there was a strong temptation to group teaching conferences in one morning. However, we will take particular care to avoid overlaps (no teaching conference at the same time as a round table or a special communication session on the same subject), and we will ensure their best placement. Likewise, we will try to avoid simultaneous presentations on the same subject as much as possible, but holding the congress over three days makes this mission delicate.
Professional themes are current and will lead to two round tables: quality of life at work and management of complications in orthopedic traumatology. We have no doubt about their success, having observed the attendance at the complications lunch debate during the 2023 congress. These round tables will be interactive based on practical situations, inspired by the format of lunch debates that have been successfully organized and led by Jean-Michel Lobry for the past 2 years.
The invited nation will be Algeria, with osteoarticular tuberculosis as the scientific theme. Apart from specialized centers (CRIOAC) and the oldest among us, this pathology had almost disappeared. However, the arrival of migrants from endemic regions with low vaccination coverage means that many of us may encounter this pathology.
Two symposiums will be presented this year with themes never before addressed in this form in our society: Post-TKR knee stiffness (Bruno Miletic, Matthieu Ehlinger) and Periprosthetic fractures on upper limb joint implants: shoulder and elbow (Pierre Mansat, Clément Tournier, Laurent Obert).
Lunch debates will see a novelty as one will be entrusted to CJO, the other two will have the themes "Certification" and "Patient data management (Congress theme 2025)".
For the 2024 congress, we will gather around the SOFCOT and CJO bureau and the stands of associated companies and partners, all discussion spaces integrating lunch debates and the "Doc en Stock" spaces and teams to create a real zone for debate and exchange.
The opening ceremony will take place after the scientific sessions on Monday at 5:30 pm. It will be followed by a cocktail where we hope to see many of you, participants, and industrial partners. Despite regular success, the "Orthobattles" will be replaced during this evening by a "Juniors vs Seniors" battle, with age limits to be defined... This battle will be followed by a convivial moment that can "reconcile" the younger and older generations after this friendly challenge.
Finally, we must amplify and continue our synergies with the industry and regulators, with whom we must have, given our reciprocal interactions, peaceful, positive, and virtuous relations.
The congress will be the highlight of 2024, but the life of CNP-COT is not limited to organizing the congress, and many of you with whom we have worked throughout the year on various scientific and professional themes can testify to this. We hope that this 2024 congress will meet everyone's aspirations by prioritizing exchanges and conviviality. Come join us and become actors of change in our profession.
Henri Migaud
SOFCOT President
Roger Badet
CNP-COT President